Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENMD-2076 in Ovarian Clear Cell Carcinoma
NCT01914510Phase 2Completed
- Sponsor
- University Health Network
- Start
- Sep 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enmd-2076 in ovarian clear cell carcinoma (OCCC), sponsored by University Health Network. Started Sep 2013; status: completed.
02
Drugs
enmd-2076
03
Conditions
ovarian clear cell carcinoma (OCCC)
Beyond the preview
Go deeper on NCT01914510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914510.